ArticleEuropean geriatric medicine2026
Association of impaired medication adherence with subsequent clinical recognition of dementia or cognitive impairment in older veterans.
Article in European geriatric medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo examine whether lower medication adherence in individuals without documented dementia or cognitive impairment (DCI) is associated with subsequent clinically recognized DCI.
methodsRetrospective cohort analysis that included veterans aged ≥ 65 years, without documented DCI at baseline, without past or current prescription for DCI medications, with ≥ 1 annual Veterans Affairs (VA) primary care visit, and with an ongoing VA prescription for any of the one or more of the following during a 3-year assessment period: lisinopril, metoprolol, omeprazole, or simvastatin. Adherence was estimated for each medication using proportion of days covered (PDC) and, secondarily, using medication possession ratio (MPR), with < 0.8 classified as low adherence. Incident DCI was determined via ICD-9/ICD-10 diagnosis codes.
resultsAnalyses included 794,569 unique veterans, separated in 4 medication cohorts (mean ages ranged from 75.6 [7.2] to 76.5 [7.2]), % male range was 98.2-98.6%). Between 16-21% of participants were categorized with low medication adherence by PDC. Over a 10-year follow-up period, incident DCI ranged from 17-18% in the low adherence group and 14-15% in the high adherence group. After multivariate adjustment, hazard for incident DCI in users of each of the four medications was significantly increased, about 20% greater among individuals with low adherence compared to those with high adherence.
conclusionAmong veterans without clinically recognized DCI, lower baseline medication adherence was associated with an increased risk for future clinically recognized DCI. Further studies should seek to disentangle whether low adherence is a risk factor for future DCI or an indicator of existing but not yet recognized DCI and whether this can inform clinical practice decisions.
Indexed as
Identifiers
41381975What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.